mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.9 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.0078 |
0.9 |